LifeStance Health Group (NASDAQ:LFST – Get Free Report) had its price target boosted by equities researchers at BTIG Research from $16.00 to $18.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s price target suggests a potential upside of 45.63% from the company’s previous close.
Other research analysts have also issued reports about the company. KeyCorp upped their price target on LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. JPMorgan Chase & Co. increased their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. Zacks Research lowered LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 13th. The Goldman Sachs Group assumed coverage on LifeStance Health Group in a research note on Friday, June 5th. They set a “neutral” rating and a $9.00 target price on the stock. Finally, Canaccord Genuity Group upped their target price on LifeStance Health Group from $11.00 to $13.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, LifeStance Health Group currently has an average rating of “Moderate Buy” and an average target price of $12.38.
View Our Latest Research Report on LifeStance Health Group
LifeStance Health Group Trading Down 1.5%
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.03. The company had revenue of $435.35 million for the quarter, compared to the consensus estimate of $414.58 million. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The company’s revenue was up 26.1% on a year-over-year basis. During the same period in the previous year, the business earned ($0.01) EPS. Research analysts forecast that LifeStance Health Group will post 0.16 EPS for the current year.
Insider Activity at LifeStance Health Group
In related news, CTO Vukasin Paunovich sold 44,394 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $481,674.90. Following the completion of the sale, the chief technology officer directly owned 247,446 shares in the company, valued at approximately $2,684,789.10. This trade represents a 15.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Lisa K. Miller sold 47,912 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $519,845.20. Following the sale, the chief operating officer directly owned 281,289 shares of the company’s stock, valued at approximately $3,051,985.65. The trade was a 14.55% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 14,629,850 shares of company stock valued at $154,952,012. Insiders own 3.50% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of LFST. Larson Financial Group LLC raised its stake in shares of LifeStance Health Group by 19,952.6% during the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after purchasing an additional 3,791 shares in the last quarter. KBC Group NV bought a new stake in shares of LifeStance Health Group in the 1st quarter valued at approximately $29,000. EverSource Wealth Advisors LLC grew its stake in shares of LifeStance Health Group by 359.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after buying an additional 5,404 shares in the last quarter. Bayesian Capital Management LP acquired a new position in LifeStance Health Group in the second quarter worth approximately $52,000. Finally, PNC Financial Services Group Inc. increased its holdings in LifeStance Health Group by 615.3% in the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock worth $59,000 after buying an additional 7,987 shares during the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.
LifeStance Health Group Company Profile
LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.
The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.
Featured Stories
- Five stocks we like better than LifeStance Health Group
- Speed Sells: Cerebras Cracks the Silicon Ceiling
- Amid Legal Risks, This Company Is Still Rated a Buy
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
